The bill directs modest, short-term federal funding and program structure to expand evidence-based TBI/mTBI care and research and clarify eligibility for veterans, but it is time-limited, modestly funded, may favor larger institutions, and risks diverting resources from other VA mental-health programs while possibly excluding some therapies.
Veterans with mTBI/TBI gain access to new, evidence-based neurorehabilitation treatments through funded clinical trials and applied programs.
Researchers, academic institutions, and nonprofits receive dedicated, predictable short-term funding (totaling roughly $30M across FY2026–FY2028) and grant opportunities to build TBI research capacity.
Clinicians and health systems get training and outreach resources to improve detection and care for mTBI, which can increase availability and quality of treatment.
Taxpayers and the VA budget face new authorized spending (about $30M over three years) and there is a risk these amounts could be drawn from existing mental-health funds, reducing resources elsewhere.
The program is time-limited (three-year pilot/sunset), risking disruption of continuity of care and long-term research and treatment development unless Congress renews or scales the program.
Limited appropriations, per-award rules, and grant structures may be insufficient for the scale of TBI needs and tend to concentrate awards at larger institutions, leaving smaller providers, rural communities, and some promising projects underfunded or excluded.
Based on analysis of 4 sections of legislative text.
Creates two VA grant programs to fund research, trials, and development of TBI treatments for veterans and authorizes about $40M for FY2026–FY2028, with reporting and independent evaluation.
Introduced January 9, 2026 by John Bergman · Last progress January 9, 2026
Creates two short-term Veterans Affairs grant programs to fund research, clinical trials, and development of neurorehabilitation treatments for traumatic brain injury (TBI) in veterans, with an emphasis on chronic mild TBI, mental-health outcomes, and suicide prevention. The bill authorizes roughly $40 million across FY2026–FY2028, sets program rules, reporting and oversight requirements, and requires an independent third party to help administer and evaluate one of the programs. Sets eligibility and award limits for nonprofit groups, academic institutions, non‑VA health providers, and other qualified entities; requires annual reporting from grantees and program-level reports to Congress; and sunsets the authorities three years after enactment.